Bristol-Myers Squibb Co : Company Partnered With Qiagen to Develop a Tissue-Based Companion Diagnostic (Cdx) for Krazati That Is Now Available
Bristol-Myers Squibb公司與Qiagen合作開發了一種基於組織的伴隨診斷(CDx),可用於Krazati。
Bristol-Myers Squibb Co : Company Partnered With Qiagen to Develop a Tissue-Based Companion Diagnostic (Cdx) for Krazati That Is Now Available
Bristol-Myers Squibb公司與Qiagen合作開發了一種基於組織的伴隨診斷(CDx),可用於Krazati。
譯文內容由第三人軟體翻譯。